Latest Jeff Kindler Stories
SAN DIEGO, Jan. 10, 2011 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) today announced the appointment of Dr. Hank McKinnell to its Board of Directors. Dr. McKinnell is the former Chief Executive Officer and former Chairman of the Board of Directors of Pfizer Inc.
NEW YORK, Dec. 5, 2010 /PRNewswire-FirstCall/ -- Pfizer Inc. (NYSE: PFE) today announced that its Board of Directors has elected Ian C. Read, 57, currently head of the Company's global biopharmaceutical operations, as President, Chief Executive Officer and Director. Mr. Read succeeds Jeffrey B.
NEW YORK, Nov.
NEW YORK May 4 /PRNewswire-FirstCall/ -- First-Quarter 2010 Revenues of $16.8 BillionFirst-Quarter 2010 Reported Diluted EPS(1) of $0.25, Adjusted Diluted EPS(2) of $0.60Reaffirms 2010 Financial Guidance and 2012 Diluted EPS Target RangesContinues to Make Solid Progress on the Wyeth Integration ($ in millions, except per share amounts) First-Quarter ------------- 2010 2009...
Pfizer has entered into a deal worth $68 billion to buy rival drug maker Wyeth, the two companies announced.
The board of Pfizer Inc.
Pfizer has posted a net income of $2.8 billion in the second quarter of 2008, an increase of 119% compared with $1.3 billion in the corresponding period of 2007.
Pfizer today announced that Frank A. D'Amelio, a
- A volcanic mudflow.